Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
The Oncologist|March 17, 2011
Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancerLeonel F Hernandez-Aya, Ana M Gonzalez-Angulo
The Surgical Clinics of North America|March 8, 2013
Adjuvant systemic therapies in breast cancerLeonel F Hernandez-Aya, Ana M Gonzalez-Angulo
Clinical Breast Cancer|September 2, 2008
Trastuzumab administration associated with change in HER2 statusShaheenah Dawood, Erika Resetkova, Ana M Gonzalez-Angulo
Seminars in Oncology|October 31, 2002
Antibody-based vaccines for the treatment of melanomaJose Lutzky, Ana M Gonzalez-Angulo, Jennifer A Orzano
Cell Cycle (Georgetown, Tex.)|September 1, 2009
Expanding the arsenal: metformin for the treatment of triple-negative breast cancer?Sao Jiralerspong, Ana M Gonzalez-Angulo, Mien-Chie Hung
Southern Medical Journal|November 12, 2002
Ifosfamide-induced encephalopathyAna M Gonzalez-Angulo, Jennifer A Orzano, Enrique Davila
The Oncologist|September 5, 2006
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancerAna M Gonzalez-Angulo, Gabriel N Hortobágyi, Francisco J Esteva
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Targeting the hepatocyte growth factor-cMET axis in cancer therapyGeorge R Blumenschein, Gordon B Mills, Ana M Gonzalez-Angulo
Women'S Health (London, England)|April 28, 2009
Breast cancer diagnosis during pregnancyJennifer K Litton, Richard L Theriault, Ana M Gonzalez-Angulo
Nature Reviews. Clinical Oncology|May 11, 2011
Targeted therapies: peaking beneath the surface of recent bevacizumab trialsAna M Gonzalez-Angulo, Gabriel N Hortobagyi, Lee M Ellis
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
The Oncologist|March 17, 2011
Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancerLeonel F Hernandez-Aya, Ana M Gonzalez-Angulo
The Surgical Clinics of North America|March 8, 2013
Adjuvant systemic therapies in breast cancerLeonel F Hernandez-Aya, Ana M Gonzalez-Angulo
Clinical Breast Cancer|September 2, 2008
Trastuzumab administration associated with change in HER2 statusShaheenah Dawood, Erika Resetkova, Ana M Gonzalez-Angulo
Seminars in Oncology|October 31, 2002
Antibody-based vaccines for the treatment of melanomaJose Lutzky, Ana M Gonzalez-Angulo, Jennifer A Orzano
Cell Cycle (Georgetown, Tex.)|September 1, 2009
Expanding the arsenal: metformin for the treatment of triple-negative breast cancer?Sao Jiralerspong, Ana M Gonzalez-Angulo, Mien-Chie Hung
Southern Medical Journal|November 12, 2002
Ifosfamide-induced encephalopathyAna M Gonzalez-Angulo, Jennifer A Orzano, Enrique Davila
The Oncologist|September 5, 2006
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancerAna M Gonzalez-Angulo, Gabriel N Hortobágyi, Francisco J Esteva
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Targeting the hepatocyte growth factor-cMET axis in cancer therapyGeorge R Blumenschein, Gordon B Mills, Ana M Gonzalez-Angulo
Women'S Health (London, England)|April 28, 2009
Breast cancer diagnosis during pregnancyJennifer K Litton, Richard L Theriault, Ana M Gonzalez-Angulo
Nature Reviews. Clinical Oncology|May 11, 2011
Targeted therapies: peaking beneath the surface of recent bevacizumab trialsAna M Gonzalez-Angulo, Gabriel N Hortobagyi, Lee M Ellis
Pageof 15